Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Utah Medical ProductsUTMD +0.41%73 5-Year Yield-on-Cost % is 2.15 as of Aug. 27, 2026, which is 32% above its 10-year median of 1.63. GuruFocus rates UTMD with a GF Score™ of 73/100 and a GF Value™ of $57.89 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 315 Medical Devices & Instruments companies, Utah Medical Products ranks worse than 54.6% on this metric.
Utah Medical Products's yield on cost for the quarter that ended in Jun. 2026 was 2.15.
The historical rank and industry rank for Utah Medical Products's 5-Year Yield-on-Cost % or its related term are showing as below:
UTMD'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.06 Med: 1.63 Max: 2.85
Current: 2.15
During the past 13 years, Utah Medical Products's highest Yield on Cost was 2.85. The lowest was 1.06. And the median was 1.63.
UTMD's 5-Year Yield-on-Cost % is ranked worse than 54.6% of 315
companies
in the Medical Devices & Instruments industry
Industry Median: 2.43
vs UTMD: 2.15
Utah Medical Products (NAS:UTMD) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Utah Medical Products 5-Year Yield-on-Cost % Related Terms
UTMD vs EMBC, SMTI, PDEX: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, Utah Medical Products's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Utah Medical Products 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Utah Medical Products's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Utah Medical Products's 5-Year Yield-on-Cost % falls into.
Utah Medical Products 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Utah Medical Products (UTMD) has a 5-Year Yield-on-Cost % of 2.15 as of Aug. 27, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Utah Medical Products and its competitors. This is 32% above median its historical median of 1.63. Over the past decade, Utah Medical Products' 5-Year Yield-on-Cost % has ranged from 1.06 to 2.85. According to the industry distribution chart, Utah Medical Products ranks #172 out of 315 companies in the Medical Devices & Instruments industry, placing it in the top 54.6%.
Is Utah Medical Products' 5-Year Yield-on-Cost % too high?
Utah Medical Products' current 5-Year Yield-on-Cost % of 2.15 is 32% above median its 10-year median of 1.63. Over the past 10 years, this metric has ranged from a low of 1.06 to a high of 2.85. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.43. Utah Medical Products' value of 2.15 is 11.5% below this industry median. Based on the distribution chart, Utah Medical Products ranks #172 out of 315 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Utah Medical Products has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Utah Medical Products' 5-Year Yield-on-Cost % compare to EMBC and SMTI?
According to the Medical Devices & Instruments industry distribution chart, Utah Medical Products ranks #172 out of 315 companies for 5-Year Yield-on-Cost %. This places Utah Medical Products in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.43. Utah Medical Products' value of 2.15 is 11.5% below this benchmark. Historically, Utah Medical Products' own 5-Year Yield-on-Cost % has ranged from 1.06 to 2.85 over the past decade. While the company's 10-year median is 1.63 vs. the industry median of 2.43, Utah Medical Products has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.43, based on 315 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Utah Medical Products's current 5-Year Yield-on-Cost % of 2.15 is 11.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Utah Medical Products and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Utah Medical Products's current 5-Year Yield-on-Cost % is 2.15, which is 32% above median its own 10-year median of 1.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Utah Medical Products stock overvalued right now?
Based on GuruFocus' analysis, Utah Medical Products (UTMD) is currently considered Modestly Overvalued. The stock's GF Value™ is $57.89, compared to a current price of $70.84 — trading 22.4% above its estimated fair value. The current 5-Year Yield-on-Cost % is 2.15, which is 32% above median its 10-year median of 1.63 and 11.5% below the Medical Devices & Instruments industry median of 2.43. Utah Medical Products' overall GF Score™ is 73/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Utah Medical Products (UTMD), the current 5-Year Yield-on-Cost % is 2.15 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Utah Medical Products (UTMD) Overvalued in 2026?
Based on GuruFocus' analysis, Utah Medical Products stock appears to be overvalued.
The current stock price of $70.84 is trading 22.4% above its estimated GF Value™ of $57.89.
GuruFocus considers Utah Medical Products to be Modestly Overvalued.
Key valuation signals for UTMD:
5-Year Yield-on-Cost %: 2.15 (32% above median its 10-year median of 1.63)
GF Value™: $57.89 vs. price of $70.84 (22.4% above fair value)
Industry Position: 11.5% below the Medical Devices & Instruments median (#172 of 315)
No single metric tells the full story. See the UTMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
73GF Score
Get the complete analysis for UTMD
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
UTMD has been successfully added to your 
